Sagimet Biosciences Inc/$SGMT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sagimet Biosciences Inc
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
Ticker
$SGMT
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
14
Website
SGMT Metrics
BasicAdvanced
$280M
-
-$1.78
-
-
Price and volume
Market cap
$280M
52-week high
$11.41
52-week low
$1.73
Average daily volume
1M
Financial strength
Current ratio
20.344
Quick ratio
20.135
Total debt to equity
0.028
Profitability
Management effectiveness
Return on assets (TTM)
-24.05%
Return on equity (TTM)
-34.72%
Valuation
Price to book
2.01
Price to tangible book (TTM)
2.01
Price to free cash flow (TTM)
-5.502
Free cash flow yield (TTM)
-18.18%
Free cash flow per share (TTM)
-1.579
Growth
Earnings per share change (TTM)
12.50%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sagimet Biosciences Inc stock?
Sagimet Biosciences Inc (SGMT) has a market cap of $280M as of August 01, 2025.
What is the P/E ratio for Sagimet Biosciences Inc stock?
The price to earnings (P/E) ratio for Sagimet Biosciences Inc (SGMT) stock is 0 as of August 01, 2025.
Does Sagimet Biosciences Inc stock pay dividends?
No, Sagimet Biosciences Inc (SGMT) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Sagimet Biosciences Inc dividend payment date?
Sagimet Biosciences Inc (SGMT) stock does not pay dividends to its shareholders.
What is the beta indicator for Sagimet Biosciences Inc?
Sagimet Biosciences Inc (SGMT) does not currently have a Beta indicator.